- Home
- ACIU vs ACB Comparison
ACIU vs ACB Comparison
Compare ACIU & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ACB
- Stock Information
- Founded
- ACIU 2003
- ACB 2013
- Country
- ACIU Switzerland
- ACB Canada
- Employees
- ACIU N/A
- ACB N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ACB Pharmaceuticals and Biotechnology
- Sector
- ACIU Health Care
- ACB Health Care
- Exchange
- ACIU Nasdaq
- ACB Nasdaq
- Market Cap
- ACIU 247.4M
- ACB 257.9M
- IPO Year
- ACIU 2016
- ACB N/A
- Fundamental
- Price
- ACIU $1.88
- ACB $4.47
- Analyst Decision
- ACIU Strong Buy
- ACB Hold
- Analyst Count
- ACIU 2
- ACB 1
- Target Price
- ACIU $12.00
- ACB N/A
- AVG Volume (30 Days)
- ACIU 187.3K
- ACB 1.0M
- Earning Date
- ACIU 03-13-2025
- ACB 02-05-2025
- Dividend Yield
- ACIU N/A
- ACB N/A
- EPS Growth
- ACIU N/A
- ACB N/A
- EPS
- ACIU N/A
- ACB 0.07
- Revenue
- ACIU $30,136,397.00
- ACB $222,964,332.00
- Revenue This Year
- ACIU $120.91
- ACB $28.17
- Revenue Next Year
- ACIU $13.82
- ACB $12.95
- P/E Ratio
- ACIU N/A
- ACB $68.07
- Revenue Growth
- ACIU 84.51
- ACB 20.72
- 52 Week Low
- ACIU $1.77
- ACB $3.42
- 52 Week High
- ACIU $4.98
- ACB $9.35
- Technical
- Relative Strength Index (RSI)
- ACIU 29.21
- ACB 45.58
- Support Level
- ACIU $1.77
- ACB $4.20
- Resistance Level
- ACIU $2.05
- ACB $4.80
- Average True Range (ATR)
- ACIU 0.12
- ACB 0.25
- MACD
- ACIU -0.02
- ACB 0.01
- Stochastic Oscillator
- ACIU 18.71
- ACB 32.93
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ACB Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.